Moderna sues Pfizer/BioNTech over Covid-19 vaccine patent

The US biotech company is alleging that the mRNA technology it developed before it copied the pandemic

Moderna said it is suing Pfizer and its German partner BioEntech for patent infringement linked to the development of the first Covid-19 vaccine.

Pfizer shares fell 1.4 percent before the bell while BioNTech fell nearly 2.0 percent.

The lawsuit, which seeks unspecified monetary damages, was filed in the United States and Germany.

The lawsuit, which seeks unspecified monetary damages, is being filed in the U.S. District Court in Massachusetts and the Regional Court in Düsseldorf, Germany, Moderna said in a news release on Friday, according to Reuters.

In a statement, Moderna said Pfizer/BioNTech copied two key elements of its intellectual property.

Pfizer said the company was not serviced and was unable to comment at this time.